Product Recalls: December 17, 2025 – January 14, 2026
Health Letter, February 2026
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS I
CLASS II
baclofen tablets, 10 mg, 1,000-count bottles. Marketed by: GSMS, Incorporated. Lot #: GS065762.
ondansetron ODT tablets, 4 mg, 1×10 unit dose tablets or 3 blistercards each containing 10 tablets. Manufactured by: Glenmark Pharmaceuticals Limited. Lot #: J1325J or I1725P, exp. date: 4/30/2027; Lot #: 19251311, exp. date: April 2027.
oxycodone and acetaminophen CII tablets, 10 mg/325 mg or 7.5 mg/325 mg, 100 tablets. Manufactured by: SpecGx LLC. Lot #: 0523J23904, exp. date: 05/2027; Lot #: 0523J24426 or 0523J24427, exp. date: 06/2027; Lot #: 0522J23493, exp. date: 03/2027.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.